global histone modification patterns predict risk prostate cancer recurrence 
aberrations post-translational modifications histones shown occur cancer cells individual promoters related clinical outcome targeted promoters modifications histones acetylation methylation lysine arginine residues also occur large regions chromatin including coding regions non-promoter sequences referred global histone modifications show changes global levels individual histone modifications also associated cancer changes predictive clinical outcome immunohistochemical staining primary prostatectomy tissue samples determined percentage cells stained histone acetylation dimethylation five residues histones h3 h4 grouping samples similar patterns modifications identified two disease subtypes distinct risks tumour recurrence patients low-grade prostate cancer histone modification patterns predictors outcome independently tumour stage preoperative prostate-specific antigen levels capsule invasion thus widespread changes specific histone modifications indicate previously undescribed molecular heterogeneity prostate cancer might underlie broad range clinical behaviour cancer patients 
